# Intravesical Gentamicin to Prevent Recurrent UTI

> **NCT06332781** · PHASE4 · COMPLETED · sponsor: **Women and Infants Hospital of Rhode Island** · enrollment: 20 (actual)

## Conditions studied

- Recurrent Uti

## Interventions

- **DRUG:** Gentamicin
- **DRUG:** Nitrofurantoin

## Key facts

- **NCT ID:** NCT06332781
- **Lead sponsor:** Women and Infants Hospital of Rhode Island
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2025-04-28
- **Primary completion:** 2025-09-30
- **Final completion:** 2026-03-31
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2026-04-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06332781

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06332781, "Intravesical Gentamicin to Prevent Recurrent UTI". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT06332781. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*